Applied Biosystems, Roche Molecular Systems, Bio-Rad, and MJ Research Reach Settlement Agreement Regarding Thermal Cyclers
The settlement also resolves patent infringement claims brought by Applera against Bio-Rad and MJ Research for infringement of Applera's Real-Time thermal cycler instrument patent, filed in November 2004 in the U.S. District Court for the District of Connecticut. Stratagene is now the sole remaining defendant in that lawsuit. Financial terms of the settlement were not disclosed.
In connection with the above settlements, Bio-Rad's 1998 thermal cycler supplier license relating to Applera's core thermal cycler patents and Roche's PCR patents has been amended to include the MJ Research thermal cyclers that were subject to the litigation with Applera and Roche. In addition, Bio-Rad has entered into a license agreement with Applera relating to Bio-Rad's Real-Time thermal cycler instrument business in the United States and Canada, and a limited license in Europe and Japan.
The settlement also resolves litigation brought by Bio-Rad against Applera for patent and trademark infringement in the U.S. District Court for the Northern District of California in 2002, and counterclaims by Applera against Bio-Rad. As part of the settlement, Applera has entered into a license agreement with Bio-Rad relating to Applera's capillary electrophoresis business.
Applera Corporation and Roche Molecular Systems originally filed this patent infringement suit in June 1998 against MJ Research relating to certain apparatus and PCR method patents owned by Applera and Roche. A jury decided in favor of Applera and Roche in April 2004. In September 2005, the Court issued an injunction prohibiting Bio-Rad, as the successor of MJ Research, from manufacturing, selling or servicing the former MJ thermal cycler products in the U.S. This settlement allows Bio-Rad to resume manufacturing, selling and servicing these products.
Most read news
Organizations
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.